The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal diseases to affect humans, regardless of whether patients receive multimodal therapy (including surgery, radiotherapy, and chemotherapy). This resistance to intervention is currently considered to be caused by the desmoplastic change...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudo, Daisuke, Suto, Akiko, Hakamada, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372616/
https://www.ncbi.nlm.nih.gov/pubmed/28282922
http://dx.doi.org/10.3390/ijms18030600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372616/
https://www.ncbi.nlm.nih.gov/pubmed/28282922
http://dx.doi.org/10.3390/ijms18030600

Ejemplares similares